Black Rock Inc. Axsome Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,299,991 shares of AXSM stock, worth $323 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,299,991
Previous 3,195,490
3.27%
Holding current value
$323 Million
Previous $255 Million
4.18%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding AXSM
# of Institutions
308Shares Held
40.3MCall Options Held
429KPut Options Held
615K-
Rtw Investments, LP New York, NY4.19MShares$410 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$391 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$231 Million37.71% of portfolio
-
Ra Capital Management, L.P. Boston, MA1MShares$97.8 Million1.21% of portfolio
-
Macquarie Group LTD Australia, C3995KShares$97.4 Million0.1% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.19B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...